Characterizing Response to Neoadjuvant Chemotherapy in Invasive Lobular Breast Carcinoma
Authors:
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Journal of Surgical Research
- Vol. 233, 436-443
Abstract
No abstract availableKeywords
Funding Information
- Harvard Catalyst,The Harvard Clinical and Translational Science Center
- National Center for Research Resources
- National Center for Advancing Translational Sciences
This publication has 28 references indexed in Scilit:
- Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapyEuropean Journal of Cancer, 2012
- Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancerBreast Cancer Research and Treatment, 2012
- The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant ChemotherapyAnnals of Surgical Oncology, 2010
- Quality Assessment of Neoadjuvant Therapy Use in Breast Conservation: Barriers to ImplementationThe Breast Journal, 2009
- Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902Breast Cancer Research and Treatment, 2008
- Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27Journal of Clinical Oncology, 2008
- Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel + G-CSFBreast Cancer Research and Treatment, 2006
- Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institutionAnnals of Oncology, 2006
- The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27Journal of Clinical Oncology, 2003
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991